Experimental Drug Shows Promise In Alzheimer’s Study

The Daily Beast reports:

In a study published Wednesday in the journal Science Translational Medicine, a group of researchers led by neuroscientists at Yale University uncovered an experimental drug taken orally that appears to reverse brain damage in mice afflicted by Alzheimer’s, and could protect the brain from future damage for at least one month.

If its success and remarkable safety can be replicated in future clinical trials in humans, the new drug, called BMS-984923, may save countless Alzheimer’s patients.

It could even prevent the disease outright for those who are at risk. While BMS-984923 seemed to be safe for rodents and monkeys, a safety trial in humans is underway and nearly complete.

Read the full article.

Scientists may be on the cusp of a treatment that can stop Alzheimer’s disease in its tracks. https://t.co/SAib9DFz4R

— The Daily Beast (@thedailybeast) June 1, 2022